HomeInsightsStock Comparison

Bajaj Healthcare Ltd vs Everest Organics Ltd Stock Comparison

Bajaj Healthcare Ltd vs Everest Organics Ltd Stock Comparison

Last Updated on: Jul 16, 2025

Key Highlights

  • The Latest Trading Price of Bajaj Healthcare Ltd is ₹ 529.15 as of 16 Jul 13:23.
  • The P/E Ratio of Bajaj Healthcare Ltd changed from 11.2 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Everest Organics Ltd changed from 7 on March 2020 to 675.3 on March 2024 . This represents a CAGR of 149.39% over 5 years.
  • The Market Cap of Bajaj Healthcare Ltd changed from ₹ 283.78 crore on March 2020 to ₹ 807.25 crore on March 2024 . This represents a CAGR of 23.26% over 5 yearsThe Market Cap of Everest Organics Ltd changed from ₹ 76 crore on March 2020 to ₹ 91.84 crore on March 2024 . This represents a CAGR of 3.86% over 5 years.
  • The revenue of Bajaj Healthcare Ltd for the Mar '25 is ₹ 168.04 crore as compare to the Dec '24 revenue of ₹ 125.17 crore. This represent the growth of 34.25% The revenue of Everest Organics Ltd for the Mar '25 is ₹ 41.15 crore as compare to the Dec '24 revenue of ₹ 42.06 crore. This represent the decline of -2.16%.
  • The ebitda of Bajaj Healthcare Ltd for the Mar '25 is ₹ 24.91 crore as compare to the Dec '24 ebitda of ₹ 20.77 crore. This represent the growth of 19.93% The ebitda of Everest Organics Ltd for the Mar '25 is ₹ 3.65 crore as compare to the Dec '24 ebitda of ₹ 4.02 crore. This represent the decline of -9.2%.
  • The net profit of Bajaj Healthcare Ltd changed from ₹ -48.21 crore to ₹ 11.18 crore over 8 quarters. This represents a CAGR of NaN% The net profit of Everest Organics Ltd changed from ₹ 0.04 crore to ₹ 2.91 crore over 8 quarters. This represents a CAGR of 752.94% .
  • The Dividend Payout of Bajaj Healthcare Ltd changed from 4.57 % on March 2021 to -3.29 % on March 2024 . This represents a CAGR of NaN% over 4 yearsThe Dividend Payout of Everest Organics Ltd changed from 7.34 % on March 2020 to 0 % on March 2024 . This represents a CAGR of -100.00% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Bajaj Healthcare Ltd

  • Incorporated in 1993, Maharashtra-based Bajaj Healthcare Limited is one of India's large scale and vertically integrated pharmaceutical manufacturer for quality-conscious customers.
  • The Company is engaged in the manufacturing of Active Pharmaceutical Ingredient (APIs), Intermediates, Finished Dosage Forms & Nutraceuticals. The Company commenced its operations in 1993 with a single unit at Tarapur.
  • It became a public company in 2005 and listed its shares in the Indian stock exchanges in 2016. With Headquartered in Thane, Company has established 3 API plants in Gujarat and Maharashtra.
  • It has 4 units for APIs/ intermediates and one unit for formulation, which are designed to meet the requirements of both advanced as well as emerging market opportunities.
  • In 2008, the Company acquired Formulations plant at Manjusar, Vadodara and have converted it into WHO-GMP compliant facility.

About Everest Organics Ltd

  • Everest Organics Limited was incorporated at Hyderabad in February, 1993.
  • It was promoted by S K Srihari Raju and S K. Chittiramabhadra Raju.
  • The Company is engaged in manufacturing of Active Pharmaceutical Ingredients and their intermediaries.
  • The Company commenced its commercial operations in the year 1993.
  • It set up a plant at Aroor, Andhra Pradesh to manufacture bulk drugs and formulations.

Bajaj Healthcare Ltd News Hub

News

Bajaj Healthcare slides after WTD Dhananjay Sabaji Hatle resigns

Bajaj Healthcare manufactures APIs and branded and generic formulations. It has five API m...

Read more

06 Jun 2025 09:56

News

Board of Bajaj Healthcare recommends final dividend

Bajaj Healthcare announced that the Board of Directors of the Company at its meeting held ...

Read more

27 May 2025 11:38

News

Bajaj Healthcare reports turnaround Q4 numbers

However, revenue from operations jumped 15.36% year-on-year (YoY) to Rs 154.47 crore in th...

Read more

27 May 2025 10:36

News

Bajaj Healthcare to convene board meeting

Bajaj Healthcare will hold a meeting of the Board of Directors of the Company on 26 May 20...

Read more

21 May 2025 15:10

News

India Ratings revises rating outlook of Bajaj Healthcare to 'stable'; affirms rating at 'A-

The agency has affirmed the company's short-term rating at 'IND A2+'. India Ratings and Re...

Read more

16 May 2025 14:41

News

Bajaj Healthcare gains after acquiring WHO-GMP certified firm Genrx Pharma

The acquisition, valued at Rs 10.85 crore through a cash consideration, involves 100% cont...

Read more

08 Apr 2025 13:22

Everest Organics Ltd News Hub

News

Everest Organics schedules board meeting

Everest Organics will hold a meeting of the Board of Directors of the Company on 27 May 20...

Read more

22 May 2025 19:46

News

Everest Organics hits the roof after securing KDMF nod for Rabeprazole Sodium API

The Rabeprazole Sodium API is primarily used to treat conditions related to excessive stom...

Read more

18 Feb 2025 15:45

News

Everest Organics to conduct board meeting

Everest Organics will hold a meeting of the Board of Directors of the Company on 11 Februa...

Read more

06 Feb 2025 13:41

News

Everest Organics to hold board meeting

Everest Organics will hold a meeting of the Board of Directors of the Company on 13 Januar...

Read more

09 Jan 2025 09:31

News

Everest Organics EGM scheduled

Everest Organics announced that an Extra Ordinary General Meeting (EGM) of the Company wil...

Read more

17 Dec 2024 17:42

News

Everest Organics spurts as board to mull fund raising on Dec 10

According to the regulatory filing, the board will discuss and approve a proposal to raise...

Read more

09 Dec 2024 11:23

SWOT Analysis Of Bajaj Healthcare Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Everest Organics Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Bajaj Healthcare Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Everest Organics Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Bajaj Healthcare Ltd and Everest Organics Ltd

Which company has a larger market capitalization, Bajaj Healthcare Ltd or Everest Organics Ltd?

Market cap of Bajaj Healthcare Ltd is 1,688 Cr while Market cap of Everest Organics Ltd is 320 Cr

What are the key factors driving the stock performance of Bajaj Healthcare Ltd and Everest Organics Ltd?

The stock performance of Bajaj Healthcare Ltd and Everest Organics Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bajaj Healthcare Ltd and Everest Organics Ltd?

As of July 16, 2025, the Bajaj Healthcare Ltd stock price is INR ₹534.6. On the other hand, Everest Organics Ltd stock price is INR ₹330.0.

How do dividend payouts of Bajaj Healthcare Ltd and Everest Organics Ltd compare?

To compare the dividend payouts of Bajaj Healthcare Ltd and Everest Organics Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions